Biochemical predictors of chronic kidney disease in children recovering from acute kidney injury
DOI:
https://doi.org/10.14739/2310-1210.2021.1.224885Keywords:
acute kidney injury, children, transferrin, ceruloplasmin, chronic kidney diseasesAbstract
The pressing question today is to find early informative markers for kidney interstitial injury in reconvalescents of acute kidney injury (AKI).
The aim of the study was to determine the informativeness of transferrin (TF), ceruloplasmin (CP) presence and activity level of lysosomal enzymes in urine as predictors of chronic kidney disease.
Materials and methods. The contents of TF, CP and N-acetyl-β-Dgluosaminindase (NAG) and β-galactosidase (ß-GAL) in the urine of 41 children after AKI were determined. All patients were divided into 2 groups depending on the disease duration – group 1 included 22 patients with 12 months’ duration, group 2 – 19 children with the disease duration of 2 years and more. The control group consisted of 28 conditionally healthy children.
Results. The levels of NAG and ß-GAL were 8 and 3 times increased, respectively, in the patients from group 1 in comparison with the control group (P < 0.001). In the group 2 children, the enzyme levels were 4 times higher than the control, and albuminuria was observed at normal GFR (P < 0.001). An inverse correlation was established between GFR indices and activity levels of NAG (r = -0.473) and ß-GAL (r = -0.333), and a direct correlation between activity indices of GAG and ß-GAL (r = 0.845). The presence and high levels of TF in 18.8 % of children in group 1 and in 21.0 % in group 2, as well as urine CP in 72.7 % of patients in group 1 and in 78.9 % in group 2, is indicative of a progressive damage to the kidney glomerular apparatus.
Conclusions. The presence and increased quantitative parameters of TF and CP in the urine of children after AKI are early signs of damage to the kidney glomerular apparatus. Four times increased levels of the enzyme activity and albuminuria at unchanged GFR indicate an interstitial kidney injury (P < 0.001). The examinations conducted are non-invasive, relatively low cost and easy to use for children of all ages.
References
Smirnov, A. V., Dobronravov, V. A., & Working group members of the Association of Nephrologists of Russia. (2016). Natsional'nye rekomendatsii. Ostroe povrezhdenie pochek: osnovnye printsipy diagnostiki, profilaktiki i terapii. Chast' I [National guidelines. Acute kidney injury: basic principles of diagnosis, prevention and therapy. Part I]. Nefrologiya, 20(1), 79-104. [in Russian].
Savenkova, N. D., & Pankov, E. A. (2015). Nereshennye problemy ostrogo povrezhdeniya pochek u detei [Acute kidney injury unsolved problems in children]. Nefrologiya, 19(3), 9-19. [in Russian].
Saran, R., Li, Y., Robinson, B., Ayanian, J., Balkrishnan, R., Bragg-Gresham, J., Chen, J. T., Cope, E., Gipson, D., He, K., Herman, W., Heung, M., Hirth, R. A., Jacobsen, S. S., Kalantar-Zadeh, K., Kovesdy, C. P., Leichtman, A. B., Lu, Y., Molnar, M. Z., Morgenstern, H., … Abbott, K. C. (2015). US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. American Journal of Kidney Diseases, 66(1, Suppl. 1), S1-S305. https://doi.org/10.1053/j.ajkd.2015.05.001
Acute Kidney Injury Work Group. (2012). KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplements, 2(1), 1-138. https://www.sciencedirect.com/journal/kidney-international-supplements/vol/2/issue/1
Coca, S. G., Singanamala, S., & Parikh, C. R. (2012). Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney International, 81(5), 442-448. https://doi.org/10.1038/ki.2011.379
Wong, C. J., Moxey-Mims, M., Jerry-Fluker, J., Warady, B. A., & Furth, S. L. (2012). CKiD (CKD in children) prospective cohort study: a review of current findings. American Journal of Kidney Diseases, 60(6), 1002-1011. https://doi.org/10.1053/j.ajkd.2012.07.018
World Health Organization. (n.d.). Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2016. WHO. https://www.who.int/healthinfo/global_burden_disease/estimates/en/
Goldstein, S. L. (2012). Acute Kidney Injury in Children and Its Potential Consequences in Adulthood. Blood Purification, 33(1-3), 131-137. https://doi.org/10.1159/000334143
Harambat, J., van Stralen, K. J., Kim, J. J., & Tizard, E. J. (2012). Epidemiology of chronic kidney disease in children. Pediatric Nephrology, 27(3), 363-373. https://doi.org/10.1007/s00467-011-1939-1
Askenazi, D. J., Feig, D. I., Graham, N. M., Hui-Stickle, S., & Goldstein, S. L. (2006). 3-5 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney International, 69(1), 184-189. https://doi.org/10.1038/sj.ki.5000032
Araki, S. (2014). Novel biomarkers for diabetic nephropathy. Rinsho Byori. The Japanese Journal of Clinical Pathology, 62(2), 171-179.
Khan, Z., & Pandey, M. (2014). Role of kidney biomarkers of chronic kidney disease: An update. Saudi Journal of Biological Sciences, 21(4), 294-299. https://doi.org/10.1016/j.sjbs.2014.07.003
Xu, Y., Xie, Y., Shao, X., Ni, Z., & Mou, S. (2015). L-FABP: A novel biomarker of kidney disease. Clinica Chimica Acta, 445, 85-90. https://doi.org/10.1016/j.cca.2015.03.017
Wasung, M. E., Chawla, L. S., & Madero, M. (2015). Biomarkers of renal function, which and when? Clinica Chimica Acta, 438, 350-357. https://doi.org/10.1016/j.cca.2014.08.039
Marchewka, Z., Kuźniar, J., & Długosz, A. (2001). Enzymuria and β2-Mikroglobulinuria in the assessment of the influence of proteinuria on the progression of glomerulopathies. International Urology and Nephrology, 33(4), 673-676. https://doi.org/10.1023/a:1020523016981
Mohkam, M., & Ghafari, A. (2015). The Role of Urinary N-acetyl-beta-glucosaminidase in Diagnosis of Kidney Diseases. Journal of Pediatric Nephrology, 3(3), 84-91. https://doi.org/10.22037/jpn.v3i3.9365
Bhavsar, N. A., Köttgen, A., Coresh, J., & Astor, B. C. (2012). Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM-1) as Predictors of Incident CKD Stage 3: The Atherosclerosis Risk in Communities (ARIC) Study. American Journal of Kidney Diseases, 60(2), 233-240. https://doi.org/10.1053/j.ajkd.2012.02.336
Price, R. G. (1992). The role of NAG (N-acetyl-beta-D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity. Clinical Nephrology, 38(Suppl. 1), S14-S19.
Liangos, O., Perianayagam, M. C., Vaidya, V. S., Han, W. K., Wald, R., Tighiouart, H., MacKinnon, R. W., Li, L., Balakrishnan, V. S., Pereira, B. J., Bonventre, J. V., & Jaber, B. L. (2007). Urinary N-Acetyl-β-(D)-Glucosaminidase Activity and Kidney Injury Molecule-1 Level Are Associated with Adverse Outcomes in Acute Renal Failure. Journal of the American Society of Nephrology, 18(3), 904-912. https://doi.org/10.1681/ASN.2006030221
Bazzi, C., Petrini, C., Rizza, V., Arrigo, G., Napodano, P., Paparella, M., & D'Amico, G. (2002). Urinary N‐acetyl‐β‐glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrology Dialysis Transplantation, 17(11), 1890-1896. https://doi.org/10.1093/ndt/17.11.1890
Narita, T., Sasaki, H., Hosoba, M., Miura, T., Yoshioka, N., Morii, T., Shimotomai, T., Koshimura, J., Fujita, H., Kakei, M., & Ito, S. (2004). Parallel Increase in Urinary Excretion Rates of Immunoglobulin G, Ceruloplasmin, Transferrin, and Orosomucoid in Normoalbuminuric Type 2 Diabetic Patients. Diabetes Care, 27(5), 1176-1181. https://doi.org/10.2337/diacare.27.5.1176
Terzic, B., Stanojevic, I., Radojicic, Z., Resan, M., Petrovic, D., Maksic, D., Djekic, J., Ristic, P., Petrovic, M., & Mijuskovic, M. (2019). Urinary transferrin as an early biomarker of diabetic nephropathy. Vojnosanitetski Pregled, 76(6), 615-619. https://doi.org/10.2298/vsp170808138t
Narita, T., Hosoba, M., Kakei, M., & Ito, S. (2005). Increased Urinary Excretions of Immunoglobulin G, Ceruloplasmin, and Transferrin Predict Development of Microalbuminuria in Patients With Type 2 Diabetes. Diabetes Care, 29(1), 142-144. https://doi.org/10.2337/diacare.29.01.06.dc05-1063
Ozkan, H., Okuturlar, Y., Koçoğlu, H., Hursitoglu, M., Gedikbasi, A., Utku, İ. K., Okuturlar, O., Dogan, H., Serin, S. O., Harmankaya, O., Demir, E., & Demir, B. (2019). Serum Levels and Urinary Excretion of Tenascin-C and TIMP-1 in Acute Kidney Injury. Clinical Laboratory, 65(10). https://doi.org/10.7754/Clin.Lab.2019.190233
Lee, S. Y., & Choi, M. E. (2015). Urinary biomarkers for early diabetic nephropathy: beyond albuminuria. Pediatric Nephrology, 30(7), 1063-1075. https://doi.org/10.1007/s00467-014-2888-2
Wang, C., Li, C., Gong, W., & Lou, T. (2013). New urinary biomarkers for diabetic kidney disease. Biomarker Research, 1(1), Article 9. https://doi.org/10.1186/2050-7771-1-9
Zheng, J., Xiao, Y., Yao, Y., Xu, G., Li, C., Zhang, Q., Li, H., & Han, L. (2013). Comparison of Urinary Biomarkers for Early Detection of Acute Kidney Injury After Cardiopulmonary Bypass Surgery in Infants and Young Children. Pediatric Cardiology, 34(4), 880-886. https://doi.org/10.1007/s00246-012-0563-6
Lopez-Giacoman, S., & Madero, M. (2015). Biomarkers in chronic kidney disease, from kidney function to kidney damage. World Journal of Nephrology, 4(1), 57-73. https://doi.org/10.5527/wjn.v4.i1.57
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
